Nona Biosciences Partners with Medical University of Vienna on Antibody Research
Nona Biosciences has partnered with the Medical University of Vienna to advance fully human antibody development for infectious diseases using its H2L2 Harbour Mice platform.
Ignaz Semmelweis Institute | 23/07/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy